Cohort profile: The Chronic Kidney Disease Prognosis Consortium

International Journal of Epidemiology

Volumn 42, Issue 6, 2013, Pages 1660-1668

  Matsushita, Kunihiro ^a   Ballew, Shoshana H ^a   Astor, Brad C ^b   de Jong, Paul E ^c   Gansevoort, Ron T ^c   Hemmelgarn, Brenda R ^d   Levey, Andrew S ^e   Levin, Adeera ^f   Wen, Chi Pang ^g,h   Woodward, Mark ^a,i   Coresh, Josef ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF CALGARY   (Canada)

^e TUFTS MEDICAL CENTER   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C;

COHORT ANALYSIS; DISEASE INCIDENCE; DISEASE TREATMENT; GUIDELINE; HEALTH STATUS; META-ANALYSIS; MORTALITY; RESEARCH PROGRAM; URINE;

ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

UNITED STATES;

ALBUMINURIA; COHORT STUDIES; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84892467829     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dys173     Document Type: Article

References (24)

1. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72:247-59.
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
3. Wen CP, Cheng TY, Tsai MK et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371:2173-82.
4. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003;14(Suppl 2):S131-38.
5. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006;17:2275-84.
6. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47.
7. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-81.
8. Gansevoort RT, Matsushita K, van der Velde M et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011;80:93-104.
9. van der Velde M, Matsushita K, Coresh J et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011;79:1341-52.
10. Astor BC, Matsushita K, Gansevoort RT et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011;79:1331-40.
11. Matsushita K, Mahmoodi BK, Woodward M et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-51.
12. Chronic Kidney Disease Prognosis Consortium (CKD-PC). http://www.jhsph.edu/ckdpc (1 August 2012, date last accessed).
13. Mahmoodi BK, Matsushita K, Woodward M et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012; doi:10.1016/S0140-6736(12)61272-0.
14. Fox CS, Matsushita K, Woodward M et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; doi:10.1016/S0140-6736(12)61350-6.
15. Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17-28.
16. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
17. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
18. Stevens LA, Coresh J, Schmid CH et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008;51:395-406.
19. Crowe E, Halpin D, Stevens P. on behalf of the Guideline Development Group. Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ 2008;337:a1530.
20. O'Hare AM, Choi AI, Bertenthal D et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007;18:2758-65.
21. Clinical Practice Guidelines: KDIGO Guideline for CKD Classification and Management. http://www.kdigo.org/clinical_ practice_guidelines/CKD.php (1 August 2012, date last accessed).
22. Sang Y, Matsushita K, Mahmoodi BK et al. Comparison of two-stage and one-stage meta-analyses: an example of eGFR-mortality association (for CKD-PC collaborators) [Abstract]. J Am Soc Nephrol 2011; 22; 445A, available from: https://www.asn-online.org/education/kidneyweek/archives/KW11Abstracts.pdf (26 October 2012, date last accessed).
23. Matsushita K, Sang Y, Woodward M et al. Assessing improvement of eGFR risk classification in meta-analysis: an example of CKD-EPI and MDRD study equations (for the CKD-PC Collaborators) [Abstract]. J Am Soc Nephrol 2011; 22; 14A, available from:https://www.asn-online.org/education/kidneyweek/archives/KW11Abstracts.pdf (26 October 2012, date last accessed).
24. Mahmoodi BK, Matsushita K, Sang Y et al. Assessing interaction on GFR-risk association in meta-analyses: an example of hypertension in the CKD prognosis consortium [Abstract]. J Am Soc Nephrol 2011; 22; 174A, available from:https://www.asn-online.org/education/kidneyweek/archives/KW11Abstracts.pdf (26 October 2012, date last accessed).